Related Experiment Video
Updated: Jan 29, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Does Postmenstrual Age Affect Medical Patent Ductus Arteriosus Treatment Success in Preterm Infants?
Sharandeep Kaur1, Amelie Stritzke2,3, Amuchou Singh Soraisham2,3
1Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Insights
Gestational age (GA), not postmenstrual age (PMA), is the key factor influencing treatment success for premature infants with patent ductus arteriosus (PDA). This finding impacts how medical interventions for PDA are approached in neonates.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Pharmacology
Background:
- Patent ductus arteriosus (PDA) is a common cardiovascular complication in premature infants.
- Effective medical management of PDA is crucial for improving outcomes in neonates.
Purpose of the Study:
- To investigate the impact of postmenstrual age (PMA) on the response to medical treatment for PDA.
- To identify predictors of successful medical PDA treatment in preterm infants.
Main Methods:
- Retrospective cohort study of infants with gestational age (GA) ≤ 32 weeks treated with nonsteroidal anti-inflammatory drugs (NSAIDs) for PDA.
- Analysis of response rates to NSAID treatment across one to three courses.
- Multivariable logistic regression using generalized estimating equations to assess the association between PMA, GA, and treatment response.
Main Results:
- A total of 183 infants received 257 courses of NSAIDs for PDA.
- The initial response rate to NSAIDs was 65.6%, with lower rates for subsequent courses.
- Postmenstrual age (PMA) was not significantly associated with a positive response to medical PDA treatment (aOR: 0.88; 95% CI: 0.71-1.10).
- Gestational age (GA) at birth was the most significant predictor of a positive response (aOR: 1.33; 95% CI: 1.02-1.73).
Conclusions:
- Gestational age at birth, rather than postmenstrual age, is the strongest predictor of successful medical treatment for patent ductus arteriosus.
- Clinical management strategies for PDA in preterm infants should prioritize factors related to initial gestational age.
Objective:
Patent ductus arteriosus (PDA) is the most common cardiovascular problem of prematurity. Our objective was to examine the effect of postmenstrual age (PMA) on response to medical PDA treatment.
Study Design:
This retrospective cohort study included infants ≤ 32 weeks' gestational age (GA) who received nonsteroidal anti-inflammatory drugs (NSAIDs) for PDA treatment. Response was positive if echocardiogram showed closed or small PDA or no further treatment was required. Baseline characteristics between responders and nonresponders were compared. Multivariable logistic regression analysis with generalized estimating equations was used to analyze the association between PMA and response.
Results:
A total of 183 infants with a mean GA of 26.4 ± 2.2 weeks and birth weight of 870 ± 313 g received 257 courses of NSAIDs. Positive response rate to the first course was 65.6%. Two and three courses were given in 62 and 12 infants, with response rates of 48.4 and 50%, respectively. Surgical ligation of PDA occurred in 30 (16.4%) infants. Multivariable logistic regression analysis with generalized estimating equations revealed that PMA was not associated with a positive response (adjusted odds ratio [aOR]: 0.88; 95% confidence interval [CI]: 0.71-1.10). GA at birth remained the most influential factor (aOR: 1.33; 95% CI: 1.02-1.73).
Conclusion:
GA rather than PMA is the strongest predictor for a positive response in medical PDA treatment.
Related Concept Videos
Ecological Succession
Role of Affect in Interpersonal Attraction
The Influence of Affect on Cognition
The Influence of Cognition on Affect
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Inhaled Medications

